Nanjing Orui Pharmaceutical
Jiangbei
About Nanjing Orui Pharmaceutical
Nanjing Orui Pharmaceutical focuses on research and development of antiviral drugs with unique ideas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $15.7M
- Funding stage: Seed
- Last round: Seed (Mar 2022)
- Website: aubrak.com
- Phone: 025-58888625
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/nanjing-orui-pharmaceutical-116043 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.